1. Home
  2. VIAV vs GKOS Comparison

VIAV vs GKOS Comparison

Compare VIAV & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$47.66

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$161.36

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
GKOS
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.7B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
VIAV
GKOS
Price
$47.66
$161.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
14
Target Price
$61.43
★ $198.69
AVG Volume (30 Days)
★ 4.9M
723.5K
Earning Date
10-28-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $1,518,300,000.00
$507,442,000.00
Revenue This Year
$24.56
$36.18
Revenue Next Year
$13.18
$23.04
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40.03
32.33
52 Week Low
$12.23
$73.16
52 Week High
$60.43
$191.62

Technical Indicators

Market Signals
Indicator
VIAV
GKOS
Relative Strength Index (RSI) 73.52 44.37
Support Level $44.41 $148.39
Resistance Level $54.68 $184.68
Average True Range (ATR) 2.13 6.29
MACD 1.33 0.38
Stochastic Oscillator 95.73 47.75

Price Performance

Historical Comparison
VIAV
GKOS

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: